{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:49:19Z","timestamp":1794361759059,"version":"4.9.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["210090"],"award-info":[{"award-number":["210090"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113717","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T15:29:01Z","timestamp":1664206141000},"page":"113717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Microneedles-based drug delivery strategies: A breakthrough approach for the management of pain"],"prefix":"10.1016","volume":"155","author":[{"given":"Sakshi","family":"Priya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113717_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121696","article-title":"Pain management with transdermal drug administration: a review","volume":"618","author":"Hu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113717_bib2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2147\/JPR.S138864","article-title":"Pain as a disease: an overview","volume":"10","author":"Raffaeli","year":"2017","journal-title":"J. Pain. Res."},{"key":"10.1016\/j.biopha.2022.113717_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jjns.12065","article-title":"Literature review of pain management for people with chronic pain","volume":"12","author":"Takai","year":"2015","journal-title":"Jpn. J. Nurs. Sci."},{"key":"10.1016\/j.biopha.2022.113717_bib4","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.biopha.2022.113717_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.biopha.2022.113717_bib6","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1097\/PRS.0000000000000682","article-title":"Pathophysiology of pain: a practical primer","volume":"134","author":"Fong","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.biopha.2022.113717_bib7","first-page":"1","article-title":"Arthritis by the numbers","volume":"3","author":"Scotton","year":"2019","journal-title":"Arthritis Found."},{"key":"10.1016\/j.biopha.2022.113717_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2147","article-title":"Current approaches in the treatment of arthritic pain","volume":"9","author":"Kidd","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113717_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2069","article-title":"Arthritis and pain. Neurogenic origin of joint pain","volume":"8","author":"McDougall","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113717_bib10","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113717_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0019-5154.152573","article-title":"Cost of care of atopic dermatitis in India","volume":"60","author":"Handa","year":"2015","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.biopha.2022.113717_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.biopha.2022.113717_bib13","doi-asserted-by":"crossref","DOI":"10.2147\/JPR.S300911","article-title":"Research trends from 2010 to 2020 for pain treatment with acupuncture: a bibliometric analysis","author":"Gao","year":"2021","journal-title":"J. Pain Res."},{"key":"10.1016\/j.biopha.2022.113717_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1529-8019.2012.01458.x","article-title":"Conventional topical delivery systems","volume":"24","author":"Weiss","year":"2011","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2022.113717_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s10544-021-00604-w","article-title":"Microneedles in diagnostic, treatment and theranostics: an advancement in minimally-invasive delivery system","volume":"24","author":"Amarnani","year":"2022","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.biopha.2022.113717_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40005-021-00512-4","article-title":"Microneedle for transdermal drug delivery: current trends and fabrication","volume":"51","author":"Jung","year":"2021","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.biopha.2022.113717_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: a smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113717_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40122-021-00286-5","article-title":"The routes of administration for acute postoperative pain medication","volume":"10","author":"Puntillo","year":"2021","journal-title":"Pain. Ther."},{"key":"10.1016\/j.biopha.2022.113717_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/pmj.77.904.82","article-title":"Non-steroidal anti-inflammatory drugs and gastrointestinal damage\u2014problems and solutions","volume":"77","author":"Russell","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.biopha.2022.113717_bib20","unstructured":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis - PubMed, (n.d.). \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/16282302\/\u3009. (Accessed 3 June 2022 )."},{"key":"10.1016\/j.biopha.2022.113717_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/rb\/rbx020","article-title":"Evaluation of repeated exposure systemic toxicity test of PVC with new plasticizer on rats via dual parenteral routes","volume":"5","author":"Hou","year":"2018","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.biopha.2022.113717_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/13543776.2016.1131267","article-title":"Topical drug delivery systems: a patent review","volume":"26","author":"Singh Malik","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2022.113717_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/187221109788452285","article-title":"Enhanced transdermal drug delivery techniques: an extensive review of patents","volume":"3","author":"Rizwan","year":"2009","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.biopha.2022.113717_bib24","article-title":"Transdermal and topical drug administration in the treatment of pain","volume":"23","author":"Leppert","year":"2018","journal-title":"Mol. A J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.biopha.2022.113717_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17425247.2022.2053674","article-title":"Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis","volume":"19","author":"Gorantla","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2022.113717_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijbiomac.2020.12.177","article-title":"Biodegradable microneedles fabricated with carbohydrates and proteins: revolutionary approach for transdermal drug delivery","volume":"170","author":"Dabholkar","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2022.113717_bib27","doi-asserted-by":"crossref","unstructured":"J. Vandervoort, A. Ludwig, Microneedles for Transdermal Drug Delivery: a Minireview, 2008.","DOI":"10.2741\/2794"},{"key":"10.1016\/j.biopha.2022.113717_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2021.06.059","article-title":"Chitosan-based microneedles as a potential platform for drug delivery through the skin: trends and regulatory aspects","volume":"184","author":"Gorantla","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2022.113717_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","article-title":"Microneedles: an emerging transdermal drug delivery system","volume":"64","author":"Bariya","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113717_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.apsb.2019.03.007","article-title":"Recent advances of microneedles for biomedical applications: drug delivery and beyond","volume":"9","author":"Yang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113717_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120491","article-title":"Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity","volume":"267","author":"Ingrole","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2022.113717_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2017.04.001","article-title":"Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: a patient friendly approach to manage arthritis","volume":"104","author":"Amodwala","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113717_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actbio.2020.12.004","article-title":"Microneedle-mediated transdermal drug delivery for treating diverse skin diseases","volume":"121","author":"Yang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2022.113717_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/adt.2020.1022","article-title":"Microneedle technology: an insight into recent advancements and future trends in drug and vaccine delivery","volume":"19","author":"Gupta","year":"2021","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.biopha.2022.113717_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11095-011-0524-4","article-title":"Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action","volume":"29","author":"Zhang","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113717_bib36","doi-asserted-by":"crossref","first-page":"eaaz9664","DOI":"10.1126\/sciadv.aaz9664","article-title":"Theranostic OCT microneedle for fast ultrahigh-resolution deep-brain imaging and efficient laser ablation in vivo","volume":"6","author":"Yuan","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.113717_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1039\/C005374K","article-title":"Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles","volume":"149","author":"Gittard","year":"2013","journal-title":"Faraday Discuss."},{"key":"10.1016\/j.biopha.2022.113717_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10020181","article-title":"Microneedle arrays combined with nanomedicine approaches for transdermal delivery of therapeutics","volume":"10","author":"Alimardani","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2022.113717_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2014.04.052","article-title":"Current advances in the fabrication of microneedles for transdermal delivery","volume":"185","author":"Indermun","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2022.113717_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pmn.2004.10.002","article-title":"Pathophysiology of neuropathic pain","volume":"5","author":"Pasero","year":"2004","journal-title":"Pain. Manag. Nurs."},{"key":"10.1016\/j.biopha.2022.113717_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WNQ.0b013e3181506c70","article-title":"The pathophysiology of neuropathic pain: a review of current research and hypotheses","volume":"17","author":"Fazen","year":"2007","journal-title":"Neurosurg. Q"},{"key":"10.1016\/j.biopha.2022.113717_bib42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2022.113717_bib43","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1021\/mp400359w","article-title":"Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine","volume":"10","author":"Kochhar","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2022.113717_bib44","article-title":"A high-dosage microneedle for programmable lidocaine delivery and enhanced local long-lasting analgesia","author":"Zhao","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biopha.2022.113717_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acsnano.6b06104","article-title":"Analgesic microneedle patch for neuropathic pain therapy","volume":"11","author":"Xie","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2022.113717_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4155\/tde-2020-0029","article-title":"Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status","volume":"11","author":"Gorantla","year":"2020","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biopha.2022.113717_bib47","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","article-title":"Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets","volume":"53","author":"Furst","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2022.113717_bib48","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1080\/17425247.2021.1950686","article-title":"CD44 receptor-targeted novel drug delivery strategies for rheumatoid arthritis therapy","volume":"18","author":"Gorantla","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2022.113717_bib49","doi-asserted-by":"crossref","unstructured":"A.I. Journal, S.P. Chegini, J. Varshosaz, S. Taymouri, Artificial Cells, Nanomedicine, and Biotechnology Recent Approaches for Targeted Drug Delivery in Rheumatoid Arthritis Diagnosis and Treatment, (2018). \u3008https:\/\/doi.org\/10.1080\/21691401.2018.1460373\u3009.","DOI":"10.1080\/21691401.2018.1460373"},{"key":"10.1016\/j.biopha.2022.113717_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2021.07.005","article-title":"Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment","volume":"336","author":"Du","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2022.113717_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11050235","article-title":"Microneedle-assisted transdermal delivery of etanercept for rheumatoid arthritis treatment","volume":"11","author":"Cao","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.113717_bib52","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/aafbbb","article-title":"Transepidermal microneedles for co-administration of folic acid with methotrexate in the treatment of rheumatoid arthritis","volume":"5","author":"Shende","year":"2019","journal-title":"Biomed. Phys. Eng. Express"},{"key":"10.1016\/j.biopha.2022.113717_bib53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/10717544.2020.1754524","article-title":"Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism","volume":"27","author":"Shu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2022.113717_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpharm.2019.03.033","article-title":"Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: a biocomfortable attempt to treat Rheumatoid Arthritis","volume":"563","author":"Yao","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113717_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118741","article-title":"Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine","volume":"572","author":"Guo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113717_bib56","first-page":"471","article-title":"Is osteoarthritis a mechanical or inflammatory disease?","volume":"48","author":"de Rezende","year":"2013","journal-title":"Rev. Bras. Ortop. (Engl. Ed. )"},{"key":"10.1016\/j.biopha.2022.113717_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.joca.2013.10.012","article-title":"Oral and topical boswellic acid attenuates mouse osteoarthritis","volume":"22","author":"Wang","year":"2014","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2022.113717_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.rehab.2016.07.004","article-title":"An update on the pathophysiology of osteoarthritis","volume":"59","author":"Mobasheri","year":"2016","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"10.1016\/j.biopha.2022.113717_bib59","first-page":"656","article-title":"Formulation and evaluation of transdermal dissolved microneedles patches for meloxicam","volume":"11","author":"Alwan","year":"2021","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"10.1016\/j.biopha.2022.113717_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121211","article-title":"Strategy for osteoarthritis therapy: improved the delivery of triptolide using liposome-loaded dissolving microneedle arrays","volume":"609","author":"Zhou","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113717_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.34133\/2020\/3672120","article-title":"Bioinspired adhesive and antibacterial microneedles for versatile transdermal drug delivery","volume":"2020","author":"Zhang","year":"2020","journal-title":"Research"},{"key":"10.1016\/j.biopha.2022.113717_bib62","article-title":"The molecular pathophysiology of psoriatic arthritis-the complex interplay between genetic predisposition, epigenetics factors, and the microbiome","volume":"8","author":"Brooks","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2022.113717_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/ar4414","article-title":"Psoriatic arthritis: recent progress in pathophysiology and drug development","volume":"15","author":"Veale","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113717_bib64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.apsb.2020.08.008","article-title":"Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis","volume":"11","author":"Yu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113717_bib65","article-title":"Microneedle mediated iontophoretic delivery of Tofacitinib Citrate","author":"Dandekar","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113717_bib66","first-page":"113","article-title":"Pathogenesis of atopic dermatitis: current concepts","volume":"3","author":"Seneviratne","year":"2021","journal-title":"J. Ski. Sex. Transm. Dis."},{"key":"10.1016\/j.biopha.2022.113717_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/exd.13808","article-title":"The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition","volume":"28","author":"Guttman-Yassky","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2022.113717_bib68","first-page":"433","article-title":"Pathophysiology of atopic dermatitis","volume":"17","author":"Grobe","year":"2019","journal-title":"JDDG J. Ger. Soc. Dermatol."},{"key":"10.1016\/j.biopha.2022.113717_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe2888","article-title":"Microneedle-assisted genome editing: a transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders","volume":"7","author":"Wan","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.113717_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.actbio.2020.07.029","article-title":"Poly-\u03b3-Glutamate microneedles as transdermal immunomodulators for ameliorating atopic dermatitis-like skin lesions in Nc\/Nga mice","volume":"114","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2022.113717_bib71","first-page":"1","article-title":"High-dose steroid dissolving microneedle for relieving atopic dermatitis","volume":"10","author":"Jang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2022.113717_bib72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2017.10.013","article-title":"Successful transdermal allergen delivery and allergen-specific immunotherapy using biodegradable microneedle patches","volume":"150","author":"Kim","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2022.113717_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-020-00176-1","article-title":"Emerging era of microneedle array for pharmaceutical and biomedical applications: recent advances and toxicological perspectives","volume":"7","author":"Dugam","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113717_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111113","article-title":"The current status of clinical research involving microneedles: a systematic review","volume":"12","author":"Jeong","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.113717_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mabi.202000307","article-title":"Hydrogel-Forming microneedles: current advancements and future trends","volume":"21","author":"Turner","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biopha.2022.113717_bib76","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopha.2017.07.019","article-title":"Dissolving microneedles for transdermal drug delivery: advances and challenges","volume":"93","author":"Ita","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113717_bib77","unstructured":"Functional Microarray Augmentation of Skin Treatment With Lidocaine - Full Text View - ClinicalTrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01145326\u3009. (Accessed 20 June, 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib78","unstructured":"The Effect of Microneedle Pretreatment on Topical Anesthesia - Full Text View - ClinicalTrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02596750\u3009. (Accessed 20 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib79","unstructured":"Adalimumab Microneedles in Healthy Volunteers - Full Text View - ClinicalTrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03607903\u3009. (Accessed 20 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib80","unstructured":"Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study - Full Text View - ClinicalTrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01737710\u3009. (Accessed 20 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib81","unstructured":"WO2011026144A1 - Use of cannabidiol prodrugs in topical and transdermal administration with microneedles - Google Patents. \u3008https:\/\/patents.google.com\/patent\/WO2011026144A1\/en?oq=PCT%2FUS2010%2F047408\u3009+. (Accessed 19 June 2022 )."},{"key":"10.1016\/j.biopha.2022.113717_bib82","unstructured":"WO2011135530A2 - Device for delivery of rheumatoid arthritis medication - Google Patents. \u3008https:\/\/patents.google.com\/patent\/WO2011135530A2\/en?oq=WO2011135530A2\u3009. (Accessed 19 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib83","unstructured":"US8784368B2 - Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - Google Patents. \u3008https:\/\/patents.google.com\/patent\/US8784368B2\/en?q=Microneedles+for+rheumatoid+arthritis&oq=Microneedles+for+rheumatoid+arthritis\u3009. (Accessed 19 June 2022 )."},{"key":"10.1016\/j.biopha.2022.113717_bib84","unstructured":"US20130144257A1 - Device for delivery of rheumatoid arthritis medication - Google Patents. \u3008https:\/\/patents.google.com\/patent\/US20130144257A1\/en\u3009. (Accessed 19 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib85","unstructured":"KR20170032801A - Soluble microneedle patch for delivery of atopic dermatitis drug - Google Patents. \u3008https:\/\/patents.google.com\/patent\/KR20170032801A\/en\u3009. (Accessed 20 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib86","unstructured":"CA2772634C - Use of cannabidiol prodrugs in topical and transdermal administration with microneedles - Google Patents. \u3008https:\/\/patents.google.com\/patent\/CA2772634C\/en?q=Microneedles+for+neuropathic+pain&oq=Microneedles+for+neuropathic+pain\u3009. (Accessed 19 June 2022 )."},{"key":"10.1016\/j.biopha.2022.113717_bib87","unstructured":"ES2679674T3 - Systems for administering medication for patients with rheumatoid arthritis - Google Patents. \u3008https:\/\/patents.google.com\/patent\/ES2679674T3\/en?oq=ES2679674T3\u3009. (19 Accessed June 2022 )."},{"key":"10.1016\/j.biopha.2022.113717_bib88","unstructured":"KR102122208B1 - Minimally invasive method for evaluating activity of atopic dermatitis using microneedle patch and minimally invasive atopic dermatitis activity evaluating kit including microneedle patch - Google Patents. \u3008https:\/\/patents.google.com\/patent\/KR102122208B1\/en?q=Microneedles%2Batopic+dermatitis&oq=Microneedles%2Batopic+dermatitis\u3009. (Accessed 20 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib89","unstructured":"JP6929784B2 - Microneedle patch formulation for delivering the active ingredient to the skin - Google Patents. \u3008https:\/\/patents.google.com\/patent\/JP6929784B2\/en?q=Microneedles+for+atopic+dermatitis&oq=Microneedles+for+atopic+dermatitis\u3009. (Accessed 19 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib90","unstructured":"CN109431967B - Soluble microneedle for treating psoriatic arthritis - Google Patents. \u3008https:\/\/patents.google.com\/patent\/CN109431967B\/en?q=Microneedles%2Bpsoriatic+arthritis&oq=Microneedles%2Bpsoriatic+arthritis\u3009. (Accessed 21 June 2022)."},{"key":"10.1016\/j.biopha.2022.113717_bib91","unstructured":"CN109528695B - Microneedle transdermal drug delivery patch for treating rheumatoid arthritis and preparation method thereof - Google Patents. \u3008https:\/\/patents.google.com\/patent\/CN109528695B\/en?q=Microneedles+for+rheumatoid+arthritis&oq=Microneedles+for+rheumatoid+arthritis\u3009. (Accessed 19 June 2022 )."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222011064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222011064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:09:03Z","timestamp":1781780943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222011064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":91,"alternative-id":["S0753332222011064"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113717","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microneedles-based drug delivery strategies: A breakthrough approach for the management of pain","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113717"}}